Results for "echocardiogram"
Conditions Encyclopedia Entry 1779068467
** Hypertrophic cardiomyopathy (HCM) is a genetic heart condition characterized by the thickening of the heart muscle, which can lead to abnormal heart function and potentially life-threatening complications. **CONTENT:** ### Overview Hypertrophic cardiomyopathy (HCM) is a complex and potentially life-threatening heart condition that affects approximately 1 in 500 people worldwide. It is the most common cause of sudden cardiac death in young athletes and is often inherited in an autosomal dominant pattern. HCM is characterized by the thickening of the heart muscle, which can lead to abnormal heart function, including reduced cardiac output, arrhythmias, and increased risk of heart failure. The symptoms of HCM can vary widely, ranging from asymptomatic to severe shortness of breath, chest pain, and fainting spells. In some cases, HCM may not cause any noticeable symptoms until it has progressed to a more advanced stage. The condition can be diagnosed through a combination of physical examination, electrocardiogram (ECG), echocardiogram, and cardiac magnetic resonance imaging (MRI). ### History/Background The first reported case of HCM dates back to 1900, when a British physician named James Parkinson described a patient with a thickened heart muscle. However, it wasn't until the 1960s that the condition was formally recognized as a distinct clinical entity. Since then, significant advances have been made in understanding the genetic and molecular mechanisms underlying HCM, as well as the development of effective treatments and management strategies. ### Key Information HCM is caused by mutations in genes that code for proteins involved in the regulation of cardiac muscle contraction and relaxation. The most common genes associated with HCM are MYBPC3, MYH7, and TNNT2. The condition can be inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition. The diagnosis of HCM typically involves a combination of clinical evaluation, ECG, echocardiogram, and cardiac MRI. The American Heart Association recommends that individuals with a family history of HCM undergo regular screening, including ECG and echocardiogram, starting at age 12. ### Significance HCM is a significant public health concern due to its high prevalence and potential for life-threatening complications. According to the American Heart Association, HCM is responsible for approximately 25% of sudden cardiac deaths in young athletes. Early detection and management of HCM can significantly improve outcomes and reduce the risk of complications. ### INFOBOX: - **Name:** Hypertrophic Cardiomyopathy (HCM) - **Type:** Genetic heart condition - **Date:** 1900 (first reported case) - **Location:** Worldwide - **Known For:** Most common cause of sudden cardiac death in young athletes ### TAGS: Genetic heart conditions, hypertrophic cardiomyopathy, sudden cardiac death, cardiac muscle thickening, heart failure, arrhythmias, cardiac MRI, echocardiogram, electrocardiogram, genetic testing. **Important Note:** If you or a family member has been diagnosed with HCM, it is essential to seek regular medical care and follow-up appointments with a cardiologist. Early detection and management of HCM can significantly improve outcomes and reduce the risk of complications.
Health & MedicineConditions Encyclopedia Entry 1780867227
Hypertrophic cardiomyopathy (HCM) is a genetic disorder that affects the heart muscle, leading to thickening of the heart walls and potentially life-threatening complications.
Health & MedicineConditions Encyclopedia Entry 1782955806
** Hypertrophic cardiomyopathy (HCM) is a genetic heart condition characterized by the thickening of the heart muscle, leading to impaired heart function and increased risk of sudden cardiac death. **CONTENT:** ### Overview Hypertrophic cardiomyopathy (HCM) is a complex and often inherited heart condition that affects the heart muscle, causing it to become abnormally thick. This thickening, known as hypertrophy, can lead to impaired heart function, reduced cardiac output, and increased risk of sudden cardiac death. HCM is a leading cause of sudden cardiac death in young athletes and is often asymptomatic in its early stages. The condition affects approximately 1 in 500 people worldwide, making it a significant public health concern. HCM can be caused by mutations in various genes that code for proteins involved in the structure and function of the heart muscle. These genetic mutations can be inherited from a parent or occur spontaneously during fetal development. The condition can also be triggered by other factors, such as high blood pressure, obesity, and certain medications. ### History/Background The first reported case of HCM dates back to 1958, when a British cardiologist named Dr. Donald Teare described a family with a history of sudden cardiac death. Since then, numerous studies have shed light on the genetic and molecular mechanisms underlying HCM. In the 1980s, researchers identified the first HCM-associated gene, MYBPC3, which codes for a protein called cardiac myosin-binding protein C. This discovery marked a significant milestone in the understanding of HCM and paved the way for the development of genetic testing and screening programs. ### Key Information HCM is characterized by the following key features: * **Hypertrophy**: Thickening of the heart muscle, particularly in the left ventricle. * **Obstruction**: Narrowing of the left ventricular outflow tract, which can lead to reduced cardiac output and increased risk of sudden cardiac death. * **Arrhythmias**: Abnormal heart rhythms, such as ventricular tachycardia and fibrillation. * **Sudden cardiac death**: Increased risk of sudden cardiac death, particularly in young athletes. Diagnosis of HCM typically involves a combination of the following: * **Echocardiogram**: Ultrasound imaging of the heart to assess heart muscle thickness and function. * **Electrocardiogram (ECG)**: Recording of the heart's electrical activity to detect arrhythmias. * **Genetic testing**: Identification of HCM-associated genes and mutations. * **Cardiac MRI**: Imaging of the heart to assess heart muscle thickness and function. ### Significance HCM is a significant public health concern due to its high prevalence and potential for sudden cardiac death. Early detection and diagnosis of HCM are crucial for preventing sudden cardiac death and improving outcomes. Genetic testing and screening programs can help identify individuals at risk and provide guidance on lifestyle modifications and treatment options. **INFOBOX:** - **Name:** Hypertrophic Cardiomyopathy (HCM) - **Type:** Genetic heart condition - **Date:** First reported case in 1958 - **Location:** Global - **Known For:** Leading cause of sudden cardiac death in young athletes **TAGS:** Hypertrophic cardiomyopathy, genetic heart condition, sudden cardiac death, heart muscle thickening, cardiac arrhythmias, genetic testing, cardiac MRI, echocardiogram, electrocardiogram.
Health & MedicineConditions Encyclopedia Entry 1779165139
** Hypertrophic cardiomyopathy (HCM) is a genetic disorder that affects the heart muscle, causing it to thicken and become stiff, leading to potential heart failure and sudden cardiac death. **CONTENT:** ### Overview Hypertrophic cardiomyopathy (HCM) is a complex and potentially life-threatening heart condition that affects approximately 1 in 500 people worldwide. It is the most common cause of sudden cardiac death in young athletes and is often inherited in an autosomal dominant pattern. HCM is characterized by the thickening of the heart muscle, particularly in the left ventricle, which can lead to impaired heart function and increased risk of complications. In individuals with HCM, the heart muscle becomes abnormally thick, which can obstruct blood flow and lead to symptoms such as chest pain, shortness of breath, and fatigue. In severe cases, HCM can cause life-threatening arrhythmias, heart failure, and even sudden cardiac death. Early diagnosis and treatment are crucial in managing HCM and preventing complications. ### History/Background The first reported cases of HCM date back to the 19th century, but it wasn't until the 1960s that the condition was formally described and named. Since then, significant advances have been made in understanding the genetic and molecular mechanisms underlying HCM. In 1990, the first genetic mutation associated with HCM was identified, and since then, numerous other mutations have been linked to the condition. ### Key Information HCM is a genetic disorder caused by mutations in genes that code for proteins involved in heart muscle contraction and relaxation. The most common mutations affect the genes encoding for cardiac myosin heavy chain (MYH7), cardiac troponin T (TNNT2), and cardiac myosin binding protein C (MYBPC3). These mutations can lead to abnormal heart muscle function, thickening, and stiffness. Symptoms of HCM can vary widely and may include: * Chest pain or angina * Shortness of breath or fatigue * Dizziness or lightheadedness * Palpitations or irregular heartbeat * Syncope (fainting) In addition to genetic testing, diagnosis of HCM typically involves a combination of: * Echocardiogram (ultrasound of the heart) * Cardiac MRI (magnetic resonance imaging) * Electrocardiogram (ECG) * Exercise stress test ### Significance HCM is a significant public health concern, particularly among young athletes and individuals with a family history of the condition. Early diagnosis and treatment can significantly improve outcomes and prevent complications. In fact, studies have shown that individuals with HCM who receive timely and appropriate treatment have a significantly reduced risk of sudden cardiac death. **INFOBOX:** - **Name:** Hypertrophic Cardiomyopathy (HCM) - **Type:** Genetic disorder - **Date:** First reported cases in the 19th century, formally described in the 1960s - **Location:** Worldwide, with a higher prevalence in certain populations - **Known For:** Most common cause of sudden cardiac death in young athletes **TAGS:** Hypertrophic cardiomyopathy, genetic disorder, heart muscle thickening, sudden cardiac death, young athletes, inherited condition, cardiac arrhythmias, heart failure, genetic testing, echocardiogram, cardiac MRI, electrocardiogram, exercise stress test.
Health & MedicineConditions Encyclopedia Entry 1779467345
** Hypertrophic cardiomyopathy (HCM) is a genetic heart condition characterized by the thickening of the heart muscle, which can lead to abnormal heart rhythms, heart failure, and sudden cardiac death. **CONTENT:** ### Overview Hypertrophic cardiomyopathy (HCM) is a complex and potentially life-threatening heart condition that affects approximately 1 in 500 people worldwide. It is the most common cause of sudden cardiac death in young athletes and is often inherited in an autosomal dominant pattern. HCM is characterized by the thickening of the heart muscle, particularly in the left ventricle, which can lead to abnormal heart rhythms, heart failure, and other complications. In HCM, the heart muscle grows abnormally thick, making it harder for the heart to pump blood efficiently. This can lead to a range of symptoms, including chest pain, shortness of breath, fatigue, and dizziness. In some cases, HCM may not cause any noticeable symptoms at all, making it essential for individuals with a family history of the condition to undergo regular screenings. ### History/Background HCM has been described in medical literature for centuries, with the first recorded case dating back to the 17th century. However, it wasn't until the 1960s that the condition was formally recognized as a distinct entity. Since then, significant advances have been made in understanding the genetic and molecular mechanisms underlying HCM, as well as the development of diagnostic and treatment options. ### Key Information HCM is caused by mutations in genes that code for proteins involved in the structure and function of the heart muscle. The most common genes associated with HCM are MYBPC3, MYH7, and TNNT2. In addition to genetic testing, diagnosis of HCM typically involves a combination of physical examination, electrocardiogram (ECG), echocardiogram, and cardiac magnetic resonance imaging (MRI). Treatment options for HCM depend on the severity of the condition and the presence of symptoms. In mild cases, lifestyle modifications such as regular exercise and a healthy diet may be sufficient. In more severe cases, medications may be prescribed to slow the heart rate, reduce symptoms, and prevent complications. In some cases, surgical interventions such as septal myectomy or alcohol septal ablation may be necessary to relieve symptoms and improve heart function. ### Significance HCM is a significant public health concern due to its high prevalence and potential for sudden cardiac death. Early detection and treatment can significantly improve outcomes and reduce the risk of complications. As a result, it is essential for individuals with a family history of HCM to undergo regular screenings and for healthcare providers to be aware of the condition and its management. **INFOBOX:** - Name: Hypertrophic Cardiomyopathy - Type: Genetic heart condition - Date: First described in the 17th century - Location: Worldwide - Known For: Most common cause of sudden cardiac death in young athletes **TAGS:** Hypertrophic cardiomyopathy, genetic heart condition, sudden cardiac death, heart failure, cardiomyopathy, heart muscle thickening, genetic testing, electrocardiogram, echocardiogram, cardiac MRI, septal myectomy, alcohol septal ablation. **When to Seek Professional Care:** If you or a family member is experiencing symptoms of HCM, such as chest pain, shortness of breath, or dizziness, seek medical attention immediately. Additionally, if you have a family history of HCM or are concerned about your risk, consult with a healthcare provider for guidance on screening and management.
Health & MedicineConditions Encyclopedia Entry 1779145384
** Atrial septal defect (ASD) is a congenital heart defect characterized by an abnormal opening in the wall between the heart's two upper chambers (atria), allowing blood to flow between them. **CONTENT:** ### Overview Atrial septal defect (ASD) is a relatively common congenital heart defect that affects approximately 1 in 2,000 births. It occurs when there is an abnormal opening in the septum, the wall of tissue that separates the heart's two upper chambers (atria). This opening allows blood to flow between the atria, disrupting the normal flow of blood through the heart. ASDs can be classified into three main types: ostium secundum, ostium primum, and sinus venosus. ASDs can cause a range of symptoms, including shortness of breath, fatigue, and palpitations. In some cases, individuals with ASDs may not experience any symptoms at all, and the condition may only be discovered during a routine physical examination or imaging test. However, if left untreated, ASDs can lead to complications such as heart failure, arrhythmias, and pulmonary hypertension. ### History/Background The first recorded description of ASDs dates back to the 17th century, when English physician Thomas Sydenham described a case of a child with a heart defect that allowed blood to flow between the atria. However, it wasn't until the 20th century that ASDs were more fully understood and classified. In the 1950s and 1960s, surgeons began to develop techniques for repairing ASDs, and the condition became more widely recognized as a treatable congenital heart defect. ### Key Information ASDs can be diagnosed using a range of imaging tests, including echocardiograms, chest X-rays, and cardiac catheterizations. Treatment options for ASDs include surgical repair, which involves closing the abnormal opening in the septum, and transcatheter closure, which uses a catheter to insert a device that closes the opening. In some cases, ASDs may be treated with medications to manage symptoms and prevent complications. ### Significance ASDs are a significant public health concern, particularly in developing countries where access to medical care may be limited. According to the World Health Organization (WHO), congenital heart defects, including ASDs, are responsible for approximately 10% of all infant deaths worldwide. In addition, ASDs can have a significant impact on an individual's quality of life, affecting their ability to engage in physical activity and participate in daily activities. **INFOBOX:** - Name: Atrial Septal Defect (ASD) - Type: Congenital heart defect - Date: First described in the 17th century - Location: Affects the heart's upper chambers (atria) - Known For: Abnormal opening in the septum between the atria **TAGS:** Atrial septal defect, congenital heart defect, heart defect, septal defect, heart surgery, transcatheter closure, echocardiogram, cardiac catheterization, pulmonary hypertension. **When to Seek Professional Care:** If you or a loved one is experiencing symptoms of an ASD, such as shortness of breath or fatigue, seek medical attention immediately. A healthcare professional can diagnose and treat ASDs, and provide guidance on managing symptoms and preventing complications.